Patents by Inventor Katherine Turner

Katherine Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Death receptors as markers for rhTRAIL-sensitivity
    Patent number: 11360077
    Abstract: Disclosed are methods and compositions for identifying and treating certain conditions and diseases. In certain instances, the general inventive concepts provide methods for determining rhTRAIL sensitivity of a sample and/or methods and compositions for inducing apoptosis to treat conditions and diseases with rhTRAIL.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: June 14, 2022
    Assignee: Cleveland State University
    Inventors: Michael Kalafatis, Katherine Turner
  • TGFBeta Antibodies, Methods and Uses
    Publication number: 20210277100
    Abstract: ProTGF?1-GARP complex-selective antibodies, polynucleotides capable of encoding the proTGF?1-GARP complex-selective antibodies or antigen-binding fragments, cells expressing proTGF?1-GARP complex-selective antibodies or antigen-binding fragments, as well as associated vectors and detectably labeled proTGF?1-GARP complex-selective antibodies or antigen-binding fragments may be used to enhance an immune response in a subject, for example, against a cancer.
    Type: Application
    Filed: May 25, 2021
    Publication date: September 9, 2021
    Inventors: Gregory J. Carven, Thomas Schurpf, Katherine Turner
  • TGFBeta Antibodies, Methods and Uses
    Publication number: 20190292254
    Abstract: ProTGFB1-GARP complex-selective antibodies, polynucleotides capable of encoding the proTGFB1-GARP complex-selective antibodies or antigen-binding fragments, cells expressing proTGFB1-GARP complex-selective antibodies or antigen-binding fragments, as well as associated vectors and detectably labeled proTGFB1-GARP complex-selective antibodies or antigen-binding fragments may be used to enhance an immune response in a subject, for example, against a cancer.
    Type: Application
    Filed: July 14, 2017
    Publication date: September 26, 2019
    Inventors: Gregory J. Carven, Thomas Schurpf, Katherine Turner
  • Death Receptors as Markers for rhTRAIL-Sensitivity
    Publication number: 20180348202
    Abstract: Disclosed are methods and compositions for identifying and treating certain conditions and diseases. In certain instances, the general inventive concepts provide methods for determining rhTRAIL sensitivity of a sample and/or methods and compositions for inducing apoptosis to treat conditions and diseases with rhTRAIL.
    Type: Application
    Filed: March 12, 2018
    Publication date: December 6, 2018
    Inventors: Michael Kalafatis, Katherine Turner
  • Metal-containing materials for treatment of bacterial conditions
    Patent number: 8425880
    Abstract: Metal-containing materials, as well as their preparation, formulations, and use are disclosed.
    Type: Grant
    Filed: April 25, 2008
    Date of Patent: April 23, 2013
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Jeffrey B. Lyczak, Katherine Thompson, Katherine Turner, Paul Schechter
  • Metal-Containing Materials for Treatment of Bacterial Conditions
    Publication number: 20130095184
    Abstract: Metal-containing materials, as well as their preparation, formulations, and use are disclosed.
    Type: Application
    Filed: April 25, 2008
    Publication date: April 18, 2013
    Applicant: NUCRYST PHARMACEUTICALS CORP.
    Inventors: Jeffrey B. Lyczak, Katherine Thompson, Katherine Turner, Paul Schechter
  • Megakaryocyte stimulating factors
    Patent number: 7361738
    Abstract: Novel polypeptides of human megakaryocyte stimulating factors (MSFs). Pharmaceutical compositions containing same, and methods for their preparation and use are provided.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: April 22, 2008
    Assignee: Genetics Institute, Inc.
    Inventors: Katherine Turner, Steven C. Clark, Kenneth Jacobs, Rodney M. Hewick, Thomas G. Gesner
  • Antibodies against CTLA4 and uses therefor
    Publication number: 20060165706
    Abstract: The invention provides an antibody-toxic moiety conjugates comprising an antibody that specifically recognizes a molecule expressed on the surface of a T cell which is expressed only on T cells and is only expressed transiently on T cells upon T cell activation. Preferably, the T cell molecule is CTLA4. The invention further provides anti-CTLA4 antibodies and humanized forms thereof.
    Type: Application
    Filed: December 29, 2005
    Publication date: July 27, 2006
    Applicant: Genetics Institute, LLC
    Inventors: Beatriz Carreno, Clive Wood, Katherine Turner, Mary Collins, Gary Gray, Donna Morris, Denise O'Hara, Paul Hinton, Naoya Tsurushita
  • Antibodies against CTLA4
    Patent number: 7034121
    Abstract: The invention provides an antibody-toxic moiety conjugates comprising an antibody that specifically recognizes a molecule expressed on the surface of a T cell which is expressed only on T cells and is only expressed transiently on T cells upon T cell activation. Preferably, the T cell molecule is CTLA4. The invention further provides anti-CTLA4 antibodies and humanized forms thereof.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: April 25, 2006
    Assignee: Genetics Institue, LLC
    Inventors: Beatriz M. Carreno, Clive Wood, Katherine Turner, Mary Collins, Gary S. Gray, Donna Morris, Denise O'Hara, Paul R. Hinton, Naoya Tsurushita
  • Megakaryocyte stimulating factors
    Patent number: 7030223
    Abstract: Novel polypeptides of human megakaryocyte stimulating factors (MSFs). Pharmaceutical compositions containing same, and methods for their preparation and use are provided.
    Type: Grant
    Filed: April 16, 2002
    Date of Patent: April 18, 2006
    Assignee: Genetics Institute LLC
    Inventors: Katherine Turner, Steven C. Clark, Kenneth Jacobs, Rodney M. Hewick, Thomas G. Gesner
  • Megakaryocyte stimulating factors
    Publication number: 20060025570
    Abstract: Novel polypeptides of human megakaryocyte stimulating factors (MSFs). Pharmaceutical compositions containing same, and methods for their preparation and use are provided.
    Type: Application
    Filed: June 28, 2005
    Publication date: February 2, 2006
    Inventors: Katherine Turner, Steven Clark, Kenneth Jacobs, Rodney Hewick, Thomas Gesner
  • Megakaryocyte stimulating factors
    Publication number: 20020137894
    Abstract: Novel polypeptides of human megakaryocyte stimulating factors (MSFs). Pharmaceutical compositions containing same, and methods for their preparation and use are provided.
    Type: Application
    Filed: April 16, 2002
    Publication date: September 26, 2002
    Applicant: Wyeth (as successor to Genetics Institute, Inc. / American Home Products)
    Inventors: Katherine Turner, Steven C. Clark, Kenneth Jacobs, Rodney M. Hewick, Thomas G. Gesner
  • Megakaryocyte stimulating factors
    Patent number: 6433142
    Abstract: Novel human megakaryocyte stimulating factors (MSFS) capable of stimulating the growth and development of colonies of megakaryocytes, pharmaceutical compositions containing same, and methods for their preparation and use are provided.
    Type: Grant
    Filed: September 10, 1991
    Date of Patent: August 13, 2002
    Assignee: Genetics Institute, LLC
    Inventors: Katherine Turner, Steven C. Clark, Kenneth Jacobs, Rodney M. Hewick, Thomas G. Gesner
  • Antibodies against CTLA4 and uses therefor
    Publication number: 20020039581
    Abstract: The invention provides an antibody-toxic moiety conjugates comprising an antibody that specifically recognizes a molecule expressed on the surface of a T cell which is expressed only on T cells and is only expressed transiently on T cells upon T cell activation. Preferably, the T cell molecule is CTLA4. The invention further provides anti-CTLA4 antibodies and humanized forms thereof.
    Type: Application
    Filed: January 26, 2001
    Publication date: April 4, 2002
    Inventors: Beatriz M. Carreno, Clive Wood, Katherine Turner, Mary Collins, Gary S. Gray, Donna Morris, Denise O'Hara, Paul R. Hinton, Naoya Tsurushita
  • Megakaryocytopoietic factor
    Patent number: 5326558
    Abstract: A novel human megakaryocytopoietic factor capable of stimulating the growth and development of colonies of megakaryocytes is provided, including procedures for its purification and use as a pharmaceutical agent.
    Type: Grant
    Filed: June 29, 1990
    Date of Patent: July 5, 1994
    Assignee: Genetics Institute, Inc.
    Inventors: Katherine Turner, Steven C. Clark, Thomas G. Gesner, Rodney M. Hewick
  • Angel in bowl figurine
    Patent number: D446159
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: August 7, 2001
    Inventor: Katherine Turner